Intellectual functioning in alpha-mannosidosis.
Sara S CatheySara M SarasuaRichard SimensenKatie PietrisGordon KimbrellDavid SillenceCallum WilsonLucia HorowitzPublished in: JIMD reports (2019)
Alpha-mannosidosis is a rare inherited metabolic disorder (OMIM #248500) caused by mutations in the enzyme α-mannosidase encoded by the gene MAN2B1. Patients have distinct physical and developmental features, but only limited information regarding standardized cognitive functioning of patients has been published. Here we contribute intellectual ability scores (IQ) on 12 patients with alpha-mannosidosis (ages 8-59 years, 10 males, 2 females). In addition, a pooled analysis was performed with data collected from this investigation and 31 cases obtained from the literature, allowing a comprehensive analysis of intellectual functioning in this rare disease. The initial and pooled analyses show that patients with alpha-mannosidosis have variable degrees of intellectual disability but show decline in IQ with age, particularly during the first decade of life. Patients treated with hematopoietic stem cell transplantation tend to show stabilized cognitive abilities.
Keyphrases
- end stage renal disease
- intellectual disability
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- systematic review
- autism spectrum disorder
- peritoneal dialysis
- physical activity
- randomized controlled trial
- mental health
- copy number
- patient reported outcomes
- clinical trial
- acute myeloid leukemia
- electronic health record
- genome wide identification